AVALUZ study: First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER-2 negative recurrent or metastatic BC: PFS analysis

Mel Lorenzo, José Ramón; Villanueva Millán, María Jesús

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/6642

DOI: 10.1158/0008-5472.SABCS11-P1-14-03

ISSN: 0008-5472

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2011

Journal title

CANCER RESEARCH

Type of content

Publicación de congreso